Higgins v. Healthsouth Corporation

CourtDistrict Court, M.D. Florida
DecidedMarch 31, 2020
Docket8:14-cv-02769
StatusUnknown

This text of Higgins v. Healthsouth Corporation (Higgins v. Healthsouth Corporation) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Higgins v. Healthsouth Corporation, (M.D. Fla. 2020).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

UNITED STATES OF AMERICA, ex rel. MELISSA HIGGINS,

Plaintiff,

v. Case No. 8:14-cv-2769-T-33AEP

HEALTHSOUTH CORPORATION n/k/a ENCOMPASS HEALTH CORPORATION,

Defendant. /

ORDER

Plaintiff Melissa Higgins (“Relator”) brought this qui tam action, as Relator, against Defendant HealthSouth Corporation n/k/a Encompass Health Corporation’s (“Encompass Health”) for violations of the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq. (Docs. 1 & 2). Currently before the Court are Relator’s request for an award of attorneys’ fees, expenses, and costs pursuant to 31 U.S.C. § 3730 and Encompass Health’s response in opposition thereto (Docs. 89, 90, 107, 116, 124, 138, 141). Essentially, Relator seeks an award under the FCA of (1) attorneys’ fees in the amount of $1,298,227 and (2) expenses and costs in the amount of $31,739.73. Upon consideration, Relator’s request for attorneys’ fees, expenses, and costs (Docs. 89 & 138) is granted in part and denied in part.2 I. Background Relator initiated this action in the Northern District of Texas against Encompass Health, alleging violations of the FCA relating to allegedly excessive fees and fraudulent billing by

2 Originally, the district judge referred the request for attorneys’ fees, costs, and expenses for issuance of a Report and Recommendation, including any related hearings, motions, and deadlines (Doc. 92). During the hearing on the initial fee application, the parties consented to Encompass Health to Medicare and other public and private health insurers (Docs. 1 & 2).3 According to Relator, she worked for Encompass Health as Director of Therapy Operations at a facility in Arlington, Texas, during most of the relevant period (Doc. 2, at ¶¶24, 36, 133-36, 165-68). After noticing potential fraudulent billing practices, Relator alleged that she raised

concerns starting around 2008 and was subsequently forced to resign (Doc. 2, at ¶¶24-28, 140- 50, 174-75). Following her alleged forced resignation, Relator filed the instant qui tam action against Encompass Health, raising the following claims under the FCA: (1) presentation of false claims; (2) making or using a false record of statement to cause a claim to be made; (3) making or using a false record of statement to avoid an obligation to refund; (4) conspiracy; and (5) retaliation (Doc. 2, at ¶¶ 161-75). Initially, the Government declined to intervene in this action but indicated that its efforts to resolve the action would continue with all parties (Doc. 73). Subsequently, the Government sought to intervene for purposes of settlement after reaching a settlement in this action and two related actions (Doc. 81), which the Court granted (Doc. 83). Thereafter, the parties submitted

a Joint Stipulation of Dismissal (Doc. 86), seeking to dismiss the action with prejudice as to Relator and the Government, except that Relator’s claims for attorneys’ fees and costs pursuant to 31 U.S.C. § 3730(d) and for retaliation pursuant to 31 U.S.C. § 3730(h) were not dismissed. Instead, the parties requested that the Court retain jurisdiction to resolve the reserved claims under 31 U.S.C. § 3730(d) and (h). Upon consideration, the Court dismissed Relator’s qui tam claims with prejudice but retained jurisdiction to resolve Relator’s claim for retaliation pursuant to 31 U.S.C. § 3730(h), as well as any claims for attorneys’ fees and costs pursuant to 31 U.S.C. § 3730(d) (Doc. 87).

3 Upon motion by the Government to transfer or consolidate, the Northern District of Texas Relator then filed her First Amended Complaint, setting forth claims for retaliation under 31 U.S.C. § 3730(h) and for attorneys’ fees, expenses, and costs under 31 U.S.C. § 3730(d) and (h) (Doc. 88). The next day, Relator moved for an award of attorneys’ fees, expenses, and costs pursuant to 31 U.S.C. § 3730(d) (Docs. 89 & 90). Specifically, Relator

sought attorneys’ fees in the amount of $1,192,726.50 and expenses in the amount of $27,702.77 (Doc. 89, at 9). Encompass Health responded in opposition, arguing that each law firm representing Relator failed to produce satisfactory evidence in support of the requested rates and that the requested rates were excessive (Doc. 107). With respect to the hours expended, Encompass Health argued that the hours were excessive, unreasonable, and either did not relate to or did not advance this litigation. Finally, as to the requested costs and expenses, Encompass Health asserted that Relator failed to sufficiently support the request and that the costs were excessive. In reply, Relator further argued the reasonableness of the requested rates, hours expended, costs, and expenses and, in addition, requested the production of Encompass Health’s billing invoices (Doc. 116).

During the pendency of the instant motion, Encompass Health moved to dismiss the First Amended Complaint (Doc. 104). After consideration, the district judge granted Encompass Health’s Motion to Dismiss, dismissed the First Amended Complaint in its entirety, and closed the case (Doc. 123). Notwithstanding, the district judge retained jurisdiction to rule on Relator’s request for attorneys’ fees, costs, and expenses and additionally directed Relator to supplement the request to explain what portion of the fees, if any, were incurred in pursuing her retaliation claim. To that end, Relator submitted her supplemental brief detailing the hours expended in pursuing her retaliation claim and identifying reductions made for such hours (Doc. 124). Subsequently, the undersigned conducted a hearing at which the parties appeared and presented oral argument on the initial application for attorneys’ fees, costs, and expenses. During the hearing, the parties indicated that they reached a stipulation as to the hourly rates for each attorney billing in this action and received an opportunity to submit supplemental

briefs. Following the hearing, the parties submitted their supplemental briefs (Doc. 138 & 141). Relator now seeks attorneys’ fees in the amount of $1,298,227 and costs and expenses in the amount of $31,739.73 (Doc. 138). Encompass Health reiterates its prior arguments and contends that the supplemental request is similarly unreasonable, especially with respect to time spent on issues unrelated to the advancement of the FCA claims and travel time and expenses for S&M’s out-of-town counsel (Doc. 141). II. Discussion Under 31 U.S.C. § 3730(d), a prevailing qui tam plaintiff may receive an award of reasonable expenses which the court finds to have been necessarily incurred, plus reasonable attorneys’ fees and costs. 31 U.S.C. § 3730(d)(1) & (2). Such fees, costs, and expenses are

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Patrol Services, Inc.
202 F. App'x 357 (Eleventh Circuit, 2006)
American Civil Liberties Union v. Barnes
168 F.3d 423 (Eleventh Circuit, 1999)
Bivins v. Wrap It Up, Inc.
548 F.3d 1348 (Eleventh Circuit, 2008)
Hensley v. Eckerhart
461 U.S. 424 (Supreme Court, 1983)
Fox v. Vice
131 S. Ct. 2205 (Supreme Court, 2011)
Marie Lucie Jean v. Alan C. Nelson
863 F.2d 759 (Eleventh Circuit, 1988)
Kearney v. Auto-Owners Insurance
713 F. Supp. 2d 1369 (M.D. Florida, 2010)
USA v. Everglades College, Inc.
855 F.3d 1279 (Eleventh Circuit, 2017)
Loranger v. Stierheim
10 F.3d 776 (Eleventh Circuit, 1994)
Nitram, Inc. v. Industrial Risk Insurers
154 F.R.D. 274 (M.D. Florida, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Higgins v. Healthsouth Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/higgins-v-healthsouth-corporation-flmd-2020.